CEO: José E. Almeida

Sector: Health Technology

Exchange: New York Stock Exchange

Country: US

Description: Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Key numbers

Market Capitalization:42270372000
Shares Outstanding: 506232000
Float: 505074247
Next Earning Date:2020-10-21
TTm EPS: 1.8148
TTm Dividend Rate: 0.905
200 days moving average:85.43
50 days moving average: 85.46
One day percent Change: 2.04

2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,